TYRP2-mediated resistance to cis-diamminedichloroplatinum (II) in human melanoma cells is independent of tyrosinase and TYRP1 expression and melanin content
暂无分享,去创建一个
B. Pak | R. Kerbel | Y. Ben-David | Q. Li
[1] B. Pak,et al. Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications , 2000, Oncogene.
[2] 西岡 恵里. Expression of tyrosinase, TRP-1 and TRP-2 in ultravioletirradiated human melanomas and melanocytes : TRP-2 protects melanoma cells from ultraviolet B induced apoptosis , 2000 .
[3] W. Hiddemann,et al. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[4] J. Westwick,et al. Cytokine-induced Apoptosis in Epithelial HT-29 Cells Is Independent of Nitric Oxide Formation , 1999, The Journal of Biological Chemistry.
[5] K. Jimbow,et al. Tyrosinase transfection produces melanin synthesis and growth retardation in glioma cells , 1998, Melanoma research.
[6] M. d’Ischia,et al. Nitric oxide-induced oxidation of 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid under aerobic conditions: non-enzymatic route to melanin pigments of potential relevance to skin (photo)protection. , 1998, Biochimica et biophysica acta.
[7] S. Gupta,et al. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. , 1998, Cancer research.
[8] H. Miyake,et al. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer , 1998, Oncogene.
[9] C. Leonetti,et al. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. , 1998, Cancer Research.
[10] C. A. Ramsden,et al. Evidence of the Indirect Formation of the Catecholic Intermediate Substrate Responsible for the Autoactivation Kinetics of Tyrosinase* , 1997, The Journal of Biological Chemistry.
[11] A. Napolitano,et al. Diffusible melanin-related metabolites are potent inhibitors of lipid peroxidation. , 1997, Biochimica et biophysica acta.
[12] Y. Vodovotz,et al. Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. , 1997, Nitric oxide : biology and chemistry.
[13] F. D’Acquisto,et al. 5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages. , 1995, Life sciences.
[14] K. Jimbow,et al. Coordinated mRNA expression of c-Kit with tyrosinase and TRP-1 in melanin pigmentation of normal and malignant human melanocytes and transient activation of tyrosinase by Kit/SCF-R , 1995, Melanoma research.
[15] C. Corsaro,et al. Melanins in physiological conditions protect against lipoperoxidation. A study on albino and pigmented Xenopus. , 1995, Pigment cell research.
[16] J. Wolchok,et al. Melanocyte differentiation marker gp75, the brown locus protein, can be regulated independently of tyrosinase and pigmentation. , 1995, The Journal of investigative dermatology.
[17] R. Kerbel,et al. Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance. , 1995, Cancer research.
[18] K. Urabe,et al. A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). , 1994, The Journal of biological chemistry.
[19] M. S. Yates,et al. The Protective Effect of Glycine in Cisplatin Nephrotoxicity: Inhibition with NG‐Nitro‐l‐arginine Methyl Ester , 1994, The Journal of pharmacy and pharmacology.
[20] G. Chu,et al. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. , 1994, The Journal of biological chemistry.
[21] J. Mordoh,et al. Role of melanin as a scavenger of active oxygen species. , 1993, Pigment cell research.
[22] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[23] P. O'Connor,et al. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines , 1992, Molecular and cellular biology.
[24] N. Copeland,et al. A second tyrosinase‐related protein, TRP‐2, maps to and is mutated at the mouse slaty locus. , 1992, The EMBO journal.
[25] V. Hearing,et al. Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] F. Solano,et al. Regulation of mammalian melanogenesis. I: Partial purification and characterization of a dopachrome converting factor: dopachrome tautomerase. , 1990, Biochimica et biophysica acta.
[27] G. Chu,et al. Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Ozols,et al. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. , 1988, Biochemical pharmacology.
[29] S. Howell,et al. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. , 1985, Cancer research.
[30] T. Ishikawa,et al. Photoprotective role of epidermal melanin granules against ultraviolet damage and DNA repair in guinea pig skin. , 1984, Cancer research.